## SEC Filings

| Date       | Form     | Description                                                                                                  | XBRL                                                                                                              | Pages |
|------------|----------|--------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------|
| 07/16/26   | SCHEDULE 13G | [Form SCHEDULE 13G: Statement of Beneficial Ownership by Certain Investors](https://ir.evommune.com/financial-information/sec-filings/content/0000919574-26-004453/primary_doc.html "Opens in a new window") |                                                                                                                   | 7     |
| 07/10/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0001757072-26-000007/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |
| 07/08/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0001290976-26-000004/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |
| 06/29/26   | 424B3    | [Form 424B3: Prospectus [Rule 424(b)(3)]](https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-286924/evmn-2026-june_29_424b3.htm "Opens in a new window")                       |                                                                                                                   | 4     |
| 06/29/26   | 8-K      | [Form 8-K: Current report](https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-286918/evmn-20260629.htm "Opens in a new window")                                           |   | 7     |
| 06/24/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0002091053-26-000005/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |
| 06/24/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0002092017-26-000007/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |
| 06/24/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000007/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |
| 06/22/26   | 144      | [Form 144: Report of proposed sale of securities](https://ir.evommune.com/financial-information/sec-filings/content/0001950047-26-006381/primary_doc.html "Opens in a new window")                       |                                                                                                                   | 2     |
| 06/03/26   | 4        | [Form 4: Statement of changes in beneficial ownership of securities](https://ir.evommune.com/financial-information/sec-filings/content/0001216994-26-000003/primarydocument.html "Opens in a new window")  |                                                                                                                   | 1     |